Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure

Article Type
Changed
Mon, 06/18/2018 - 14:21
Display Headline
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure
Interpreting the African American Heart Failure Trial (A-HeFT)
Article PDF
Author and Disclosure Information

Monica Colvin-Adams, MD
Assistant Professor of Medicine/Cardiology; Medical Director, Cardiac Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN

Anne L. Taylor, MD
Professor of Medicine/Cardiology and Associate Dean for Faculty Affairs, University of Minnesota Medical School; Codirector, University of Minnesota National Center of Excellence in Women’s Health; Chair, Steering Committee, African-American Heart Failure Trial (A-HeFT)

Address: Anne L. Taylor, MD, University of Minnesota Medical School, C694 Mayo Memorial Building, Mayo Mail Code 293, 420 Delaware Street, S.E., Minneapolis, MN 55455; e-mail: taylo135@umn.edu

Dr. Taylor has indicated that she has received research support and consulting fees from the NitroMed corporation, which also sponsored the African-American Heart Failure Trial.

Issue
Cleveland Clinic Journal of Medicine - 74(3)
Publications
Topics
Page Number
227-234
Sections
Author and Disclosure Information

Monica Colvin-Adams, MD
Assistant Professor of Medicine/Cardiology; Medical Director, Cardiac Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN

Anne L. Taylor, MD
Professor of Medicine/Cardiology and Associate Dean for Faculty Affairs, University of Minnesota Medical School; Codirector, University of Minnesota National Center of Excellence in Women’s Health; Chair, Steering Committee, African-American Heart Failure Trial (A-HeFT)

Address: Anne L. Taylor, MD, University of Minnesota Medical School, C694 Mayo Memorial Building, Mayo Mail Code 293, 420 Delaware Street, S.E., Minneapolis, MN 55455; e-mail: taylo135@umn.edu

Dr. Taylor has indicated that she has received research support and consulting fees from the NitroMed corporation, which also sponsored the African-American Heart Failure Trial.

Author and Disclosure Information

Monica Colvin-Adams, MD
Assistant Professor of Medicine/Cardiology; Medical Director, Cardiac Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN

Anne L. Taylor, MD
Professor of Medicine/Cardiology and Associate Dean for Faculty Affairs, University of Minnesota Medical School; Codirector, University of Minnesota National Center of Excellence in Women’s Health; Chair, Steering Committee, African-American Heart Failure Trial (A-HeFT)

Address: Anne L. Taylor, MD, University of Minnesota Medical School, C694 Mayo Memorial Building, Mayo Mail Code 293, 420 Delaware Street, S.E., Minneapolis, MN 55455; e-mail: taylo135@umn.edu

Dr. Taylor has indicated that she has received research support and consulting fees from the NitroMed corporation, which also sponsored the African-American Heart Failure Trial.

Article PDF
Article PDF
Interpreting the African American Heart Failure Trial (A-HeFT)
Interpreting the African American Heart Failure Trial (A-HeFT)
Issue
Cleveland Clinic Journal of Medicine - 74(3)
Issue
Cleveland Clinic Journal of Medicine - 74(3)
Page Number
227-234
Page Number
227-234
Publications
Publications
Topics
Article Type
Display Headline
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure
Display Headline
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media